Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic

NCT04867265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-06-03

No results posted yet for this study

Summary

Complex practical BLS training have been stopped all over the world due to COVID-19 pandemic in 2020. While launching the new Simulation Centre at Medical Faculty of Masaryk University in Brno, Czech Republic, teachers and students have been dealing with the risk of COVID-19 transmission during the simulation training. One of the highest risks for the transfer of COVID-19 between the medical students is during the mouth-to-mouth ventilation training in BLS.

It has been assumed that rescuers during BLS simulation training with use of breathable nanofiber respirator with layers with accelerated copper can provide efficient mouth-to-mouth rescue breaths to the mannequin in compliance with safety rules.

Conditions

  • Ventilation During Resuscitation

Interventions

PROCEDURE

Mout-to-mouth ventilation

we will record the visibility of chest rising

PROCEDURE

Mout-to-mouth ventilation with quantitative analysis

we will record the visibility of chest rising, review the ventilation metrics and evaluate each rescue breath in QCPR Skill Reporter

Sponsors & Collaborators

  • Masaryk University

    collaborator OTHER
  • Brno University Hospital

    lead OTHER

Principal Investigators

  • Martina Kosinova, assoc. prof. MD., Ph.D. · Faculty of medicince Masaryk University and University Hospital Brno

  • Petr Štourač, prof.MD.Ph.D. · Faculty of medicince Masaryk University and University Hospital Brno

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2021-06-02
Completion
2021-06-02

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04867265 on ClinicalTrials.gov